Skip to main content
PLEASE NOTE: For everyone’s safety, Fasken requires anyone on-site at our Canadian and Johannesburg offices to provide proof of full vaccination against COVID-19. This applies to lawyers, staff, clients, service providers and other visitors.
Client Work

US based manufacturer of recombinant human glycoprotein conducts clinical trial program

Fasken
Reading Time 1 minute read Subscribe

Overview

Client

Confidential Client

Timothy Squire of Fasken Martineau was retained by a US based manufacturer of recombinant human glycoprotein to assist with their clinical trial program and market authorization, including protocol, agreements, classification and submission.

Team

    Subscribe

    Receive email updates from our team

    Subscribe